|1.||Li, Shengnan: 3 articles (12/2013 - 08/2009)|
|2.||Jin, Lai: 3 articles (12/2013 - 08/2009)|
|3.||Ikegaki, Ichiro: 3 articles (09/2009 - 02/2008)|
|4.||Seto, Minoru: 3 articles (09/2009 - 02/2008)|
|5.||Asano, Toshio: 3 articles (09/2009 - 02/2008)|
|6.||Hammock, Bruce D: 3 articles (06/2009 - 04/2005)|
|7.||King, Michael R: 2 articles (10/2015 - 07/2015)|
|8.||Mitchell, Michael J: 2 articles (10/2015 - 07/2015)|
|9.||Castellanos, Carlos A: 2 articles (10/2015 - 07/2015)|
|10.||Banerjee, Rinti: 2 articles (01/2014 - 04/2007)|
08/15/1967 - "Lauric acid-induced thrombocytopenia and thrombosis in rabbits."
11/18/2011 - "More pathological signs of lesions, higher grades of pathological thrombosis, increased blood platelet counts, the increase in the TXB2 and TXB2/6-K-PGF(1α) ratio, as well as the decrease of 6-K-PGF(1α) in TAO model group were shown in present experiments; SFI treatment significantly improved the pathological signs of lesions induced by sodium laurate injection, reduced the numbers of thrombus formation, blood platelet counts, the TXB2 and TXB2/6-K-PGF(1α) ratio but increased the 6-K-PGF(1α) compared with TAO model group. "
09/01/2000 - "Rats were anesthetized with sodium pentobarbital, and 100 microg of sodium laurate was injected into the left internal carotid artery on days 1 and 3. The thrombus induction and consequent of ischemic brain damage were examined by histopathological analyses and neurological deficit scoring in a posture reflex test. "
08/01/1989 - "Its effect on obstruction of the peripheral artery was studied in three different models: 1. acute thrombosis induced by electrical-stimulation of the femoral artery in rabbits, 2. occlusion induced by intra-arterial injection of sodium laurate in rats and 3. tail gangrene induced by subcutaneous injections of both ergotamine and epinephrine in rats. "
05/01/1973 - "Effect of metabolic inhibitors on lauric acid-induced hemolysis."
04/01/1990 - "The results are summarized as follows: (A) not only at 37 degrees, but also at 42 degrees and 47 degrees C lauric acid (12:0) represents the minimum chain length for the biphasic behaviour of protecting against hypotonic hemolysis at a certain lower concentration range and hemolysis promotion at subsequent higher concentrations; (B) with increasing temperatures the protecting as well as the hemolytic effects occur at lower concentrations of the fatty acids; (C) the increase of temperature promotes the extent of hemolysis and reduces the extent of protection against hypotonic hemolysis; (D) Gamma-irradiation of erythrocytes selectively affects the concentration of oleic acid at which maximum protection against hypotonic hemolysis occurs, without altering the minimum concentration for 100% hemolysis."
10/06/1988 - "The results are summarized as follows: (A) the fatty acids examined exhibit a high degree of specificity in their thermotropic behavior; (B) oleic acid protects against hypotonic hemolysis even at the highest concentrations, up to 15 degrees C, when it becomes hemolytic, but only in a limited concentration range; (C) elaidic acid does not affect the osmotic stability of erythrocytes up to 20 degrees C, when it starts protecting: above 30 degrees C, it becomes hemolytic at the highest concentrations; (D) palmitoleic acid is an excellent protecting agent at all temperatures in a certain concentration range, becoming hemolytic at higher concentrations; (E) lauric acid protects up to 30 degrees C and becomes hemolytic only above this temperature; (F) myristic acid exhibits an extremely unusual behavior at 30 and 37 degrees C by having alternating concentration ranges of protecting and hemolytic effects; (G) there is a common critical temperature for hemolysis at 30 degrees C for saturated and trans-unsaturated fatty acids; (H) the initial slope of Arrhenius plots of percent hemolysis at the concentration of maximum protection is negative for cis-unsaturated fatty acids and positive for saturated and trans-unsaturated fatty acids."
03/01/2010 - "We demonstrated that chronic treatment of spontaneously hypertensive stroke-prone rats with 12-(3-adamantan-1-yl-ureido) dodecanoic acid, an inhibitor of SEH, improved the increment of inward remodeling induced by common carotid ligation to a level that was comparable with normotensive Wistar Kyoto rats. "
06/01/2009 - "Here we show that 6 weeks of SEH inhibition via 2 mg/day of 12-(3-adamantan-1-yl-ureido) dodecanoic acid (AUDA) in spontaneously hypertensive stroke-prone (SHRSP) rats protects against cerebral ischemia induced by middle cerebral artery occlusion, reducing percent hemispheric infarct and neurodeficit score without decreasing blood pressure. "
01/01/2014 - "Lauric acid in crown daisy root exudate potently regulates root-knot nematode chemotaxis and disrupts Mi-flp-18 expression to block infection."
01/01/2005 - "Its activity was not influenced by the presence of solid particles and did not cease at pH > 6. Lauric acid might be a means for control of clostridial infections in farm animals."
01/01/2001 - "Lauric acid did not inactivate virion infectivity neither interacted with the cell to induce a state refractory to virus infection. "
11/01/2013 - "Four- to six-week-old male specific pathogen-free BALB/c mice were inoculated intranasally with 10(5) 50% tissue culture infective doses (TCID50) of highly pathogenic A/Chicken/Hebei/108/2002 (H5N1) viruses and were then given 1000 IU of lauric acid modified superoxide dismutase (LA-SOD) by intraperitoneal injection, starting 2 days post-infection and continuing for 6 days. "
01/21/2014 - "A strategy was developed to target infections by producing coatings made of non-toxic chemistries lauric acid and oleic acid delivered by core-shell solid lipid nanoparticles that act against bacteria by multiple mechanisms at the nanoscale, including disruption of bacteria leading to DNA release, and reducing the adhesion of dead bacteria to ~1%. "
|1.||Fatty Acids (Saturated Fatty Acids)
|2.||Oleic Acid (Oleate)
|4.||Butyric Acid (Butanoic Acid)
|6.||Prostaglandins F (PGF)
|7.||Volatile Oils (Essential Oils)
|8.||cinnamic aldehyde (cinnamaldehyde)
|9.||lauric acid (dodecanoic acid)
|2.||Heterologous Transplantation (Xenotransplantation)
|4.||Quantum Dots (Quantum Dot)